CD274 and cancer: The present study showed similarities in PD-L1 binding efficacy and in vitro functional capabilities in comparison with mammalian cell-based antibody Tecentriq®, thereby inferring the potentiality of plant-produced Atezolizumab for use in cancer therapeutics.